Matthew R. Henn

Insider Reports History

Entity
Individual
Location
C/O Seres Therapeutics, Inc., 200 Sidney Street, Cambridge, MA
Signature
/s/ Thomas J. DesRosier, attorney-in-fact for Matthew R. Henn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew R. Henn:

Insider Reports Filed by Matthew R. Henn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MCRB Seres Therapeutics, Inc. Nov 15, 2024 3 -$501 4 Nov 19, 2024 Chief Scientific Officer and EVP
MCRB Seres Therapeutics, Inc. Oct 27, 2024 3 -$2.75K 4 Oct 29, 2024 Chief Scientific Officer and EVP
MCRB Seres Therapeutics, Inc. Aug 15, 2024 3 -$775 4 Aug 19, 2024 Chief Scientific Officer and EVP
MCRB Seres Therapeutics, Inc. May 15, 2024 3 -$838 4 May 17, 2024 Chief Scientific Officer and EVP
MCRB Seres Therapeutics, Inc. Feb 14, 2024 6 -$4.5K 4 Feb 16, 2024 Chief Scientific Officer and EVP
MCRB Seres Therapeutics, Inc. Oct 27, 2023 4 -$5.25K 4 Oct 31, 2023 Chief Scientific Officer and EVP
MCRB Seres Therapeutics, Inc. Apr 27, 2023 1 $0 4 May 1, 2023 Chief Scientific Officer and EVP
MCRB Seres Therapeutics, Inc. Feb 3, 2023 2 $0 4 Feb 7, 2023 Chief Scientific Officer and EVP
MCRB Seres Therapeutics, Inc. Sep 8, 2022 1 $0 4 Sep 9, 2022 Chief Scientific Officer and EVP
MCRB Seres Therapeutics, Inc. Jul 5, 2022 1 $150K 4 Jul 6, 2022 Chief Scientific Officer and EVP
MCRB Seres Therapeutics, Inc. Feb 4, 2022 1 $0 4 Feb 8, 2022 Chief Scientific Officer and EVP